Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease
The Klinrisk model accurately identified patients with type 2 diabetes and CKD requiring the most healthcare resources. Such tools can support the identification and targeting of high-risk patients for interventions that may lead to a more cost-effective model of care.
Authors
- Sophie Gao (ORCID: https://orcid.org/0009-0007-3685-2319)
- Thomas W. Ferguson (ORCID: https://orcid.org/0000-0003-1058-943X)
- Silvia J. Leon (ORCID: https://orcid.org/0000-0003-0006-9596)
- Reid Whitlock (ORCID: https://orcid.org/0000-0002-7046-0358)
- Samuel Fatoba
- Hongjiao Liu (ORCID: https://orcid.org/0000-0003-4845-5170)
- Keith A. Betts (ORCID: https://orcid.org/0000-0002-3088-7453)
- Navdeep Tangri (ORCID: https://orcid.org/0000-0002-5075-6370)
- Yuxian Du (ORCID: https://orcid.org/0000-0003-2369-0553)
- Jingyi Chen (ORCID: https://orcid.org/0000-0003-0012-9640)
- A.K. Singh (ORCID: https://orcid.org/0000-0003-1875-3994)
- Rakesh K. Singh (ORCID: https://orcid.org/0000-0003-3235-9934)
- Youssef M.K. Farag (ORCID: https://orcid.org/0000-0003-1692-1851)
- Arvind Katta
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Bayer (United States) (US)
- Seven Oaks General Hospital (CA)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1007/s13300-025-01787-8
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00